CORC  > 复旦大学上海医学院
Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen
Timmers, Marijke; Roex, Gils; Wang, Yuedi; Campillo-Davo, Diana; Van Tendeloo, Viggo F., I; Chu, Yiwei; Berneman, Zwi N.; Luo, Feifei; Van Acker, Heleen H.; Anguille, Sebastien
刊名FRONTIERS IN IMMUNOLOGY
2019
卷号10
关键词chimeric antigen receptor-modified T cells immunotherapy multiple myeloma B cell maturation antigen CD19 CD138 CD38 SLAMF7/CS1
ISSN号1664-3224
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3597656
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Timmers, Marijke,Roex, Gils,Wang, Yuedi,et al. Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen[J]. FRONTIERS IN IMMUNOLOGY,2019,10.
APA Timmers, Marijke.,Roex, Gils.,Wang, Yuedi.,Campillo-Davo, Diana.,Van Tendeloo, Viggo F., I.,...&Anguille, Sebastien.(2019).Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen.FRONTIERS IN IMMUNOLOGY,10.
MLA Timmers, Marijke,et al."Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen".FRONTIERS IN IMMUNOLOGY 10(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace